Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K

Journal of Bone and Mineral Research

Volumn 16, Issue 8, 2001, Pages 1444-1452

  Kiviranta, Riku ^a   Morko, Jukka ^a   Uusitalo, Hannele ^a   Aro, Hannu T ^a   Vuorio, Eero ^a   Rantakokko, Juho ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Bone remodeling; Histomorphometry; Osteoclast; Osteoporosis; Quantitative computed tomography

Indexed keywords

CATHEPSIN K;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; METAPHYSIS; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; TRABECULAR BONE; TRANSGENIC MOUSE;

ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; CATHEPSINS; FEMUR; GENE EXPRESSION; HUMANS; IMMUNOCHEMISTRY; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOCLASTS; RNA, MESSENGER; SKULL; TISSUE DISTRIBUTION;

EID: 0034924044     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.8.1444     Document Type: Article

References (46)

1. Pathogenesis of osteoporosis and fracture
2. Diagnosis of osteoporosis in clinical practice
3. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
4. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype
5. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
6. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
7. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice
8. Cathepsin K: Isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene
9. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice
10. Osteopetrosis in cathepsin K-deficient mice
11. Cathepsin K
12. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts
13. Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development
14. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry
15. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix
16. The collagenolytic activity of cathepsin K is unique among mammalian proteinases
17. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency
18. A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis
19. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
20. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
21. The osteoblast-specific transcription factor cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function
22. Complete genomic structure of the mouse cathepsin k gene (ctsk) and its localization next to the arnt gene on mouse chromosome 3
23. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
24. Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs
25. Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model
26. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development
27. Cloning and characterization of the 5′-flanking region of the mouse tartrate-resistant acid phosphatase gene
28. Structure and expression of osteonectin mRNA in human tissue
29. Differential expression of extracellular proteins is correlated with angiogenesis in vitro
30. Cathepsin expression during skeletal development
31. Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia
32. Processing of undecalcified bone specimens for bone histomorphometry
33. Bone histomorphometry: Standardization of nomenclature, symbols, and units
34. Bone formation and factors affecting this process
35. Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression
36. Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain
37. Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice
38. Transgenic mice overexpressing tartrate resistant acid phosphatase exhibit an increased rate of bone turnover
39. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
40. Pathologic gene expression in Gaucher disease: Up-regulation of cysteine proteinases including osteoclastic cathepsin K
41. Skeletal involvement in Gaucher's disease
42. Mechanism of bone turnover
43. Novel regulators of bone formation: Molecular clones and activities
44. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor betal in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation
45. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages